Disease: Spinocerebellar ataxia 3
- A model for the dynamics of expanded CAG repeat alleles: <em>ATXN2</em> and <em>ATXN3</em> as prototypes
- A pilot study: handgrip as a predictor in the disease progression of SCA3
- Antisense Oligonucleotide Silencing Reverses Abnormal Neurochemistry in Spinocerebellar Ataxia 3 Mice
- ASO silencing reverses abnormal neurochemistry in spinocerebellar ataxia 3 mice
- ASOs are an effective treatment for disease-associated oligodendrocyte signatures in premanifest and symptomatic SCA3 mice
- Autophagy in Spinocerebellar Ataxia Type 3: From Pathogenesis to Therapeutics
- Blood and cerebellar abundance of ATXN3 splice variants in spinocerebellar ataxia type 3/Machado-Joseph disease
- Blood levels of neurofilament light are associated with disease progression in a mouse model of spinocerebellar ataxia type 3
- Case report: Short-term efficacy and changes in <sup>18</sup>F-FDG-PET with acute multi-target stimulation in spinocerebellar ataxia type 3 (SCA3/MJD)
- Cell-Free and In Vivo Characterization of the Inhibitory Activity of <em>Lavado</em> Cocoa Flavanols on the Amyloid Protein Ataxin-3: Toward New Approaches against Spinocerebellar Ataxia Type 3
- Cognitive-affective manifestations since premanifest phases of Spinocerebellar Ataxia Type 3/Machado-Joseph Disease
- Compressed cerebellar functional connectome hierarchy in spinocerebellar ataxia type 3
- Correction to: The frequency of non-motor symptoms in SCA3 and their association with disease severity and lifestyle factors
- Correction to: The frequency of non‑motor symptoms in SCA3 and their association with disease severity and lifestyle factors
- Cross talk about the role of Neuropeptide Y in CNS disorders and diseases
- Drug repurposing of dopaminergic drugs to inhibit ataxin-3 aggregation
- Establishment of human-induced pluripotent stem cell GZHMCi0011-A from peripheral blood mononuclear cells from a volunteer with 14/63 CAG repeats of the ATXN3 mutation
- Factors Influencing Health-Related Quality of Life of Patients with Spinocerebellar Ataxia
- Gene editing as a therapeutic strategy for spinocerebellar ataxia type-3
- Genetic Ablation of Inositol 1,4,5-Trisphosphate Receptor Type 2 (IP<sub>3</sub>R2) Fails to Modify Disease Progression in a Mouse Model of Spinocerebellar Ataxia Type 3
- Genetic Epidemiology and Clinical Characteristics of Patients with Spinocerebellar Ataxias in an Unexplored Brazilian State, Using Strategies for Resource-Limited Settings
- Genetic screening for Huntington disease phenocopies in Sweden: A tertiary center case series focused on short tandem repeat (STR) disorders
- Glucocorticoid receptor-dependent therapeutic efficacy of tauroursodeoxycholic acid in preclinical models of spinocerebellar ataxia type 3
- Graft-derived neurons and bystander effects are maintained for six months after human iPSC-derived NESC transplantation in mice's cerebella
- IL-4/STAT6 axis observed to reverse proliferative defect in SCA3 patient-derived neural progenitor cells
- Implications of specific lysine residues within ataxin-3 for the molecular pathogenesis of Machado-Joseph disease
- Improvement of spinocerebellar ataxia 3 symptoms treated with Eurythmy Therapy - A Case Vignette
- Improvement of Spinocerebellar Ataxia 3 Symptoms Treated with Eurythmy Therapy: A Case Vignette
- In Memoriam: Paula Coutinho (1941-2022), a pioneer in Neurogenetics
- Investigating the therapeutic effects of novel compounds targeting inflammatory IL-1β and IL-6 signaling pathways in spinocerebellar ataxia type 3
- Lysine 117 on ataxin-3 modulates toxicity in <em>Drosophila</em> models of Spinocerebellar Ataxia Type 3
- Lysine 117 on ataxin-3 modulates toxicity in Drosophila models of Spinocerebellar Ataxia Type 3
- Machado-Joseph disease in a Sudanese family links East Africa to Portuguese families and allows reestimation of ancestral age of the Machado lineage
- Mitochondrial Dysfunction and Decreased Cytochrome <em>c</em> in Cell and Animal Models of Machado-Joseph Disease
- Modification of Huntington's disease by short tandem repeats
- O-GlcNAcylation and Its Roles in Neurodegenerative Diseases
- Pharmacological inhibition of acetylcholinesterase improves the locomotion defective phenotype of a SCA3 <em>C. elegans</em> model
- PolyQ-Expansion Causes Mitochondria Fragmentation Independent of Huntingtin and Is Distinct from Traumatic Brain Injury (TBI)/Mechanical Stress-Mediated Fragmentation Which Results from Cell Death
- Preconditioning of exosomes derived from human olfactory ensheathing cells improved motor coordination and balance in an SCA3/MJD mouse model: A new therapeutic approach
- Prevalence of repeat expansions causing autosomal dominant spinocerebellar ataxias in Hokkaido, the northernmost island of Japan
- Progression of Retinal Ganglion Cell and Nerve Fiber Layer Loss in Spinocerebellar Ataxia 3 Patients
- Regional and age-dependent changes in ubiquitination in cellular and mouse models of spinocerebellar ataxia type 3
- Roles of the cerebellum and basal ganglia in temporal integration: Insights from a synchronized tapping task
- Spermidine treatment: induction of autophagy but also apoptosis?
- Spinocerebellar Ataxia Type 3 Pathophysiology-Implications for Translational Research and Clinical Studies
- Stage-dependent biomarker changes in spinocerebellar ataxia type 3
- Stage-Dependent Biomarker Changes in Spinocerebellar Ataxia Type 3
- T2-hyperintensity in the internal globus pallidus in Machado-Joseph disease
- Temporal Relationship between Impairment of Cerebellar Motor Learning and Deterioration of Ataxia in Patients with Cerebellar Degeneration
- The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases
- THE HIDDEN VESTIBULAR FEATURES OF MACHADO JOSEPH DISEASE (SPINOCEREBELLAR ATAXIA 3)
- The longitudinal progression of MRI changes in pre-ataxic carriers of SCA3/MJD
- The natural breakthrough: phytochemicals as potent therapeutic agents against spinocerebellar ataxia type 3
- The overarching effects of vestibular deficit: Imbalance, anxiety, and spatial disorientation
- The vestibular symptomatology of Machado-Joseph Disease
- Therapeutic effects of engineered exosome-based miR-25 and miR-181a treatment in spinocerebellar ataxia type 3 mice by silencing ATXN3
- Tissue-Specific Vulnerability to Apoptosis in Machado-Joseph Disease
- Towards Understanding Neurodegenerative Diseases: Insights from <em>Caenorhabditis elegans</em>
- Treatment with sodium butyrate induces autophagy resulting in therapeutic benefits for spinocerebellar ataxia type 3
- Viral-based animal models in polyglutamine disorders